Cargando…

Response to Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide—Should Consideration Be Given to Cannalicular Efflux Transporters?

Detalles Bibliográficos
Autores principales:	Hopkins, AM, Foster, DJR, Wiese, MD, Upton, RN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Response to Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625860/ https://www.ncbi.nlm.nih.gov/pubmed/26535156 http://dx.doi.org/10.1002/psp4.12036

Ejemplares similares

Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide: Should Consideration Be Given to Cannalicular Efflux Transporters?
por: Srinivas, NR
Publicado: (2015)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Painful Small Fiber Neuropathy Associated With Teriflunomide: A Case Series and Literature Review Related to Teriflunomide and Leflunomide
por: Elrefaey, Ahmed, et al.
Publicado: (2023)

Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide
por: Terekhova, Irina, et al.
Publicado: (2020)

On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations
por: Kujawski, Jacek, et al.
Publicado: (2015)

From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis
por: Aly, Lilian, et al.
Publicado: (2017)

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
por: Bilger, Andrea, et al.
Publicado: (2017)

Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels
por: Fajardo-Robledo, Nicte S., et al.
Publicado: (2022)

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021)

Why NIPT should be publicly funded
por: Bunnik, Eline Maria, et al.
Publicado: (2020)

Why we should not extend the 14-day rule
por: Blackshaw, Bruce Philip, et al.
Publicado: (2021)

Should we move to a genomic classification of neutrophilic myeloid neoplasms?
por: Carreño-Tarragona, Gonzalo, et al.
Publicado: (2023)

Ethical considerations for protecting the options of subjects in primary epidemic vaccine trials
por: Caplan, Arthur L, et al.
Publicado: (2021)

Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
por: Potnis, Kunal C., et al.
Publicado: (2023)

COVID-19: should oral vaccination strategies be given more consideration?
por: Mehan, Aman, et al.
Publicado: (2020)

Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Commentary on muscle dysmorphia as an addiction: A response to Grant (2015) and Nieuwoudt (2015)
por: GRIFFITHS, MARK D., et al.
Publicado: (2015)

Dentists should be more familiar with systemic management [Response To Letter]
por: Sato, Hikaru, et al.
Publicado: (2021)

Further considerations on rotavirus vaccination and seizure-related hospitalization rates
por: Gómez-Rial, Jose, et al.
Publicado: (2019)

Diemer and Swanson Reply to “Considerations Before Using Pandemic as Instrument”
por: Diemer, Elizabeth W, et al.
Publicado: (2021)

Interactive Pharmacometric Applications Using R and the Shiny Package
por: Wojciechowski, J, et al.
Publicado: (2015)

What Should Clinicians Do for Older Adults with Polypharmacy and Depression? [Response to Letter]
por: Cheng, Cheng, et al.
Publicado: (2022)

We Should Agree to Disagree
por: Park, Joon Soo, et al.
Publicado: (2021)

Should Dogs and Cats be Given as Gifts?
por: Weiss, Emily, et al.
Publicado: (2013)

Teriflunomide Concentrations in Cerebrospinal Fluid and Plasma in Patients with Multiple Sclerosis: A Pharmacokinetic Study
por: Lycke, Jan, et al.
Publicado: (2023)

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients
por: Luo, Man (Melody), et al.
Publicado: (2020)

Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?
por: Fabbian, Fabio, et al.
Publicado: (2016)

Should Finasteride Be Routinely Given Preoperatively for TURP?
por: Aboumarzouk, O. M., et al.
Publicado: (2013)

Why and When Bacterial Vaccines Should Be Given
por: Wells, W. Frank
Publicado: (1913)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Teriflunomide: Lack of efficacy: case report
Publicado: (2022)

Lichenoid Drug Eruption Induced by Teriflunomide
por: Agharbi, Fatima-Zahra, et al.
Publicado: (2023)

Should activated charcoal be given after tramadol overdose?
por: Khosrojerdi, Hamid, et al.
Publicado: (2013)

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
por: Kim, Sung-Tae, et al.
Publicado: (2011)

Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)
por: Kim, Soon Ae, et al.
Publicado: (2011)

Response: The Effects of Low-Calorie Diets on Abdominal Visceral Fat, Muscle Mass, and Dietary Quality in Obese Type 2 Diabetic Subjects (Korean Diabetes J 2009;33:526-36)
por: Ahn, Hee-Jung, et al.
Publicado: (2010)

Response: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55)
por: Kim, Hyeon Chang
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ojbajrfqiecv8llj6plode6vc